Adaptive Treatment Margins to Reduce Organs at Risk Dose in Patients with No or Minimal Anatomical Changes in Radiotherapy of Non-small Cell Lung Cancer

Overview

Journal Phys Imaging Radiat Oncol

Specialty Oncology

Date 2025 Feb 12

PMID 39935553

Authors

Djoya Hattu

Daisy Emans

Janine Bouten

Richard Canters

Judith van Loon

Dirk De Ruysscher

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: In non-small cell lung cancer (NSCLC) a significant portion of the planning target volume (PTV) margin accommodates for anatomical changes during treatment. Patients with no or minimal anatomical changes might therefore benefit from a reduced PTV margin, resulting in lower organ at risk (OAR) doses. We evaluated a plan of the day approach using different PTV margins to quantify its effect on OAR and clinical target volume (CTV) dose.

Materials And Methods: Twenty NSCLC patients were included in this retrospective study. CBCTs of all fractions were evaluated using an image-guided radiotherapy (IGRT) protocol to classify fractions into two groups: no or minimal anatomical changes to which reduced PTV margin plans (5 or 2 mm) were assigned, or with anatomical changes that received the reference treatment plan (8 mm PTV margin). OAR doses were investigated and CTV coverage was evaluated using CBCT dose recalculations.

Results: All plans showed decreased OAR dose when the PTV margin was reduced from 8 mm to 5 mm or 2 mm. The IGRT protocol selected 254/600 fractions in 19/20 patients, that could be treated with a smaller margin. CTV V remained ≥95% in 94% of the 5 mm plans and 87% of the 2 mm plans, compared to 98% of the reference 8 mm plans.

Conclusion: The IGRT protocol could identify fractions with no or minimal anatomical changes allowing a plan of the day approach to reduce PTV margins. Target coverage remained adequate in the majority of patients, while reducing OAR doses.

References

Gregoire V, Mackie T . State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother. 2011; 15(6-7):555-9. DOI: 10.1016/j.canrad.2011.04.003. View

Piperdi H, Portal D, Neibart S, Yue N, Jabbour S, Reyhan M . Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field. Front Oncol. 2021; 11:770382. PMC: 8666420. DOI: 10.3389/fonc.2021.770382. View

Hattu D, Mannens J, Ollers M, van Loon J, De Ruysscher D, van Elmpt W . A traffic light protocol workflow for image-guided adaptive radiotherapy in lung cancer patients. Radiother Oncol. 2022; 175:152-158. DOI: 10.1016/j.radonc.2022.08.030. View

Moller D, Khalil A, Knap M, Hoffmann L . Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis. Radiother Oncol. 2013; 110(3):517-22. DOI: 10.1016/j.radonc.2013.10.013. View

Sharfo A, Breedveld S, Voet P, Heijkoop S, Mens J, Hoogeman M . Validation of Fully Automated VMAT Plan Generation for Library-Based Plan-of-the-Day Cervical Cancer Radiotherapy. PLoS One. 2016; 11(12):e0169202. PMC: 5199117. DOI: 10.1371/journal.pone.0169202. View

Kwint M, Conijn S, Schaake E, Knegjens J, Rossi M, Remeijer P . Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. Radiother Oncol. 2014; 113(3):392-7. DOI: 10.1016/j.radonc.2014.10.009. View

Thummerer A, Zaffino P, Meijers A, Marmitt G, Seco J, Steenbakkers R . Comparison of CBCT based synthetic CT methods suitable for proton dose calculations in adaptive proton therapy. Phys Med Biol. 2020; 65(9):095002. DOI: 10.1088/1361-6560/ab7d54. View

van Diessen J, Kwint M, Sonke J, Walraven I, Stam B, de Langen A . Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients. Radiother Oncol. 2019; 143:66-72. DOI: 10.1016/j.radonc.2019.07.028. View

Taasti V, Hattu D, Peeters S, van der Salm A, van Loon J, De Ruysscher D . Clinical evaluation of synthetic computed tomography methods in adaptive proton therapy of lung cancer patients. Phys Imaging Radiat Oncol. 2023; 27:100459. PMC: 10314284. DOI: 10.1016/j.phro.2023.100459. View

10.

Nelson C, Starkschall G, Chang J . The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volume. Int J Radiat Oncol Biol Phys. 2006; 65(2):573-86. DOI: 10.1016/j.ijrobp.2006.01.032. View

11.

Lutkenhaus L, Visser J, De Jong R, Hulshof M, Bel A . Evaluation of delivered dose for a clinical daily adaptive plan selection strategy for bladder cancer radiotherapy. Radiother Oncol. 2015; 116(1):51-6. DOI: 10.1016/j.radonc.2015.06.003. View

12.

Heijkoop S, Langerak T, Quint S, Bondar L, Mens J, Heijmen B . Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Int J Radiat Oncol Biol Phys. 2014; 90(3):673-9. DOI: 10.1016/j.ijrobp.2014.06.046. View

13.

Yeung A, Li J, Shi W, Newlin H, Chvetsov A, Liu C . Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009; 74(4):1100-7. DOI: 10.1016/j.ijrobp.2008.09.048. View

14.

De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans C, Le Pechoux C . European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol. 2017; 124(1):1-10. DOI: 10.1016/j.radonc.2017.06.003. View

15.

Fox J, Ford E, Redmond K, Zhou J, Wong J, Song D . Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008; 74(2):341-8. DOI: 10.1016/j.ijrobp.2008.07.063. View

16.

Buschmann M, Majercakova K, Sturdza A, Smet S, Najjari D, Daniel M . Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique. Z Med Phys. 2017; 28(3):184-195. DOI: 10.1016/j.zemedi.2017.09.004. View

17.

Hoegen P, Lang C, Akbaba S, Haring P, Splinter M, Miltner A . Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung. Front Oncol. 2020; 10:564857. PMC: 7756078. DOI: 10.3389/fonc.2020.564857. View

18.

Bissonnette J, Purdie T, Higgins J, Li W, Bezjak A . Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2008; 73(3):927-34. DOI: 10.1016/j.ijrobp.2008.08.059. View

19.

De Jong R, Lutkenhaus L, van Wieringen N, Visser J, Wiersma J, Crama K . Plan selection strategy for rectum cancer patients: An interobserver study to assess clinical feasibility. Radiother Oncol. 2016; 120(2):207-11. DOI: 10.1016/j.radonc.2016.07.027. View

20.

Gao L, Xie K, Wu X, Lu Z, Li C, Sun J . Generating synthetic CT from low-dose cone-beam CT by using generative adversarial networks for adaptive radiotherapy. Radiat Oncol. 2021; 16(1):202. PMC: 8515667. DOI: 10.1186/s13014-021-01928-w. View